Rainer Henning, Chief Executive Officer

Viravaxx
discovery, research and development Rainer Henning
Chief Executive Officer

Welcome by the CEO

Viravaxx and the Medical University of Vienna together have launched a new project for development of an integrated immunodiagnostic and vaccination platform to answer the challenge posed by the current Covid-19 pandemic.

By joining our forces, we expect to make a significant contribution to the efforts of the biopharmaceutical industry to overcome this unprecented threat. More information can be found here.